Fat necrosis after breast-conserving oncoplastic surgery

被引:26
|
作者
Nakada, Haruka [1 ]
Inoue, Masayuki [1 ]
Furuya, Kazushige [1 ]
Watanabe, Hideki [1 ]
Ikegame, Kou [1 ]
Nakayama, Yuko [2 ]
Ohmori, Masato [2 ]
Nakagomi, Hiroshi [1 ]
机构
[1] Yamanashi Prefectural Cent Hosp, Dept Breast Surg, Fujimi1-1-1, Kofu, Yamanashi 4008506, Japan
[2] Univ Yamanashi, Dept Surg 1, Yamanashi, Japan
关键词
Fat necrosis; Breast-conserving oncoplastic surgery; Free dermal fat flap; Pedicled fat flap; SURGICAL ADJUVANT BREAST; TUMOR RECURRENCE; CANCER; RADIOTHERAPY; THERAPY; WOMEN; IRRADIATION; LUMPECTOMY; CARCINOMA; RADIATION;
D O I
10.1007/s12282-018-0901-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundFat necrosis is a subjective early as well as delayed complication, which sometimes mimics local recurrence and ruins the quality of life by pain and poor cosmetic result. While, the frequency and severity of fat necrosis are important issues that breast surgeons should explain to the patient, these data are not revealed well.MethodsA total of 1476 patients who underwent breast surgery from January 2000 to December 2012 were enrolled in the present study. We assessed fat necrosis by mammographic and physical findings and created grading criteria: Grade (G) 0, no fat necrosis; G1, no symptomatic fat necrosis (mammographic dystrophic calcification); G2, mild symptomatic necrosis (mammographic dystrophic necrosis with tumor); G3, severe symptomatic necrosis (mammographic dystrophic necrosis with pain or skin change); and G4, symptomatic necrosis requiring surgical intervention.ResultsOf the 1476 patients enrolled, 393 (27%) underwent mastectomy, and 1083 (73%) underwent breast-conserving surgery. We achieved a high rate of breast-conserving surgery at a total rate of 73% over the study period and maximum rate of 88% in 2010, using oncoplastic procedures. We mainly adopted a pedicled fat flap (417/1083; 39%) and a free dermal fat flap (40/1083; 3.7%). Among the 626 patients who underwent partial resection with no replacement for the defect, G1-G2 fat necrosis was seen in 29/626 (4.6%). While, the incidence of fat necrosis with pedicled fat flap and free dermal fat graft was 68/417 (16%) and 40/40 (100%), respectively, showing a significant difference (p<0.01). Furthermore, the incidence of G3-G4 fat necrosis was significantly higher with free dermal fat grafts (25%; 10/40) than with pedicled flap (2.9%; 12/417) (p<0.01). Among pedicled flaps, the incidence of fat necrosis with inframammary adipofascial flaps was 56% (14/25) which was higher than that with lateral epidermal fat flaps (12%; 33/276) (p<0.01), and rotation of surrounding breast tissues (8%; 21/116) (p<0.01). The incidence of G3 fat necrosis was also high at 20% (5/25) in inframammary adipofascial flaps.ConclusionsBreast-conserving oncoplastic surgery carries a risk of fat necrosis as a delayed complication. The incidence rate and severity of fat necrosis with each procedure should be assessed. We should select fat grafts with a good blood supply to replace defects of breast-conserving therapy.
引用
收藏
页码:125 / 130
页数:6
相关论文
共 50 条
  • [41] Oncoplastic breast-conserving surgery in breast cancer treatment Systematic review of the literature
    Papanikolaou, Joannis G.
    ANNALI ITALIANI DI CHIRURGIA, 2016, 87 (03) : 199 - 208
  • [42] Oncological Advantages of Oncoplastic Breast-Conserving Surgery in Treatment of Early Breast Cancer
    Down, Sue K.
    Jha, Pankaj K.
    Burger, Amy
    Hussien, Maged I.
    BREAST JOURNAL, 2013, 19 (01): : 56 - 63
  • [43] A Lost Opportunity: Oncoplastic Surgery's Critical Role in Breast-Conserving Surgery
    Clemens, Mark W.
    BREAST DISEASES, 2016, 27 (02): : 104 - 107
  • [44] Advancements of breast-conserving therapy using oncoplastic surgery in the management of breast cancer
    Gabka, CJ
    Maiwald, G
    Baumeister, RG
    EFFICIENCY AND ECONOMICS OF CLINICAL CARE AND RESEARCH IN SURGERY, 1997, SUPPL : 1224 - 1227
  • [45] Quality of information reporting in studies of standard and oncoplastic breast-conserving surgery
    Schaverien, M. V.
    Doughty, J. C.
    Stallard, S.
    BREAST, 2014, 23 (02): : 104 - 111
  • [46] Opioids Are Not Required for Pain Control Following Oncoplastic Breast-Conserving Surgery
    Ramiscal, Judi Anne B.
    Mandelbaum, Ava D.
    Orozco, Javier
    Wilson, Ana K.
    Lee, Nathaniel A.
    Lorimer, Patrick D.
    Grumley, Janie G.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 2) : S329 - S330
  • [47] Trends in Lumpectomy and Oncoplastic Breast-Conserving Surgery in the US, 2011–2016
    Chloe Christina Kimball
    Christine Ida Nichols
    Joshua Greene Vose
    Anne Warren Peled
    Annals of Surgical Oncology, 2018, 25 : 3867 - 3873
  • [48] Challenges in utilizing oncoplastic techniques in breast-conserving surgery - A Canadian perspective
    Maxwell, Jessica
    Covelli, Andrea
    Scheer, Adena
    Roberts, Amanda
    Osman, Fahima
    Escallon, Jaime
    Cil, Tulin
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : 244 - 245
  • [49] Feasibility and safety of oncoplastic breast-conserving surgery through an inframammary incision
    Fayed, Haytham
    Yousry, Joseph
    El-Fayomi, Tarek
    Al-Husseini, Mahmoud
    EGYPTIAN JOURNAL OF SURGERY, 2022, 41 (03): : 1094 - 1100
  • [50] Use of boost radiotherapy in oncoplastic breast-conserving surgery - A systematic review
    Schaverien, M. V.
    Stallard, S.
    Dodwell, D.
    Doughty, J. C.
    EJSO, 2013, 39 (11): : 1179 - 1185